Oropharyngeal colostrum immunotherapy and risk reduction of mortality in very low birth weight premature newborns: a clinical trial
Open Access
- 7 September 2023
- journal article
- research article
- Published by Elsevier in Jornal de Pediatria
- Vol. 100 (1) , 32-39
Abstract
No abstract availableKeywords
Funding Information
- Fundação de Amparo à Pesquisa do Estado da Bahia
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
- Conselho Nacional de Desenvolvimento Científico e Tecnológico (4996/2017)
This publication has 25 references indexed in Scilit:
- Effect of oropharyngeal colostrum therapy in the prevention of necrotising enterocolitis among very low birthweight neonates: A meta‐analysis of randomised controlled trialsJournal of Human Nutrition and Dietetics, 2018
- Maternal and neonatal factors related to prematurityRevista da Escola de Enfermagem da USP, 2016
- Buccal administration of human colostrum: impact on the oral microbiota of premature infantsJournal of Perinatology, 2015
- Oropharyngeal Colostrum Administration in Extremely Premature Infants: An RCTPediatrics, 2015
- Early Administration of Oropharyngeal Colostrum to Extremely Low Birth Weight InfantsBreastfeeding Medicine, 2013
- Exploring the Use of Mothers' Own Milk as Oral Care for Mechanically Ventilated Very Low-Birth-Weight Preterm InfantsAdvances in Neonatal Care, 2013
- CONSORT 2010 Statement: Updated Guidelines for Reporting Parallel Group Randomized TrialsAnnals of Internal Medicine, 2010
- Oropharyngeal administration of colostrum to extremely low birth weight infants: theoretical perspectivesJournal of Perinatology, 2008
- Evaluation of the secretory immunoglobulin A levels in the colostrum and milk of mothers of term and pre-trerm newbornsThe Brazilian Journal of Infectious Diseases, 2005
- What's the Relative Risk?JAMA, 1998